NSE filing, NSE: BLISSGVS. Summary written from the filing by ALFA Finder's alert engine.
Bliss GVS Pharma Ltd: key numbers
- Share price
- ₹656.35
- Market cap
- ₹6,983 Cr
- Revenue (annual)
- ₹927.1 Cr
- Net profit (annual)
- ₹129.1 Cr
- P/E (TTM)
- 43.3×Sector 48.6×
- Promoter holding
- 50.07%+15.06% QoQ
- FII holding
- 5.03%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Bliss GVS Pharma Ltd
All →Bliss GVS Pharma Legal & Regulatory
Bliss GVS Pharma was fined Rs. 1,80,000 (excluding GST) by BSE and NSE for failing to appoint a woman director. The fine has been paid to the regulators.
- Value
- ₹0.02 Cr
- From
- BSE Limited and National Stock Exchange of India Limited
Bliss GVS Pharma Regulatory Approval
Bliss GVS Pharma's UK subsidiary Asterisk Lifesciences received MHRA marketing authorisation for Mesalazine 1g Suppositories. The approval lets the subsidiary market the product in the UK.
Bliss GVS Pharma Q2 FY27 Results: Net Profit ₹53.3 Cr, Up 86.4% YoY
Bliss GVS Pharma Ltd reported revenue from operations of ₹313.4 Cr (+28.2% YoY) and net profit of ₹53.3 Cr (+86.4% YoY) for Q2 FY27.
- Key figure
- Net profit ₹53.3 Cr · +86.4% YoY
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bliss GVS Pharma Board Meeting Date
Bliss GVS Pharma Ltd scheduled a board meeting for October 29, 2026, to approve the company's unaudited financial results for the quarter ending September 30, 2026.
Bliss GVS Pharma Other Announcement
Bliss GVS Pharma Ltd has filed its quarterly shareholding pattern report for the period ended September 30, 2026.
Other annual general meeting announcements
All →Khazanchi Jewellers Annual General Meeting
Khazanchi Jewellers' EGM on November 17, 2026 approved Ms. Simran Lodha's appointment as Independent Director for three years. The resolution was a special resolution passed via e-voting.
Solara Active Pharma Sciences Annual General Meeting
Solara Active Pharma seeks postal ballot approval for revised remuneration of its whole-time director and managing director. E-voting closes 17 December 2026.
Prataap Snacks Annual General Meeting
Prataap Snacks issued a postal ballot notice seeking approval to appoint Jitendra Nayyar and Sumit Sharma as directors and to reclassify some promoter group members as public. Voting ends December 18, 2026.
Sayaji Hotels Annual General Meeting
Sayaji Hotels filed a postal ballot notice seeking shareholder approval to appoint two non-executive non-independent directors. E-voting runs from 18 November to 18 December 2026.
Coreintegra Consulting Services Annual General Meeting
Coreintegra seeks postal ballot approval to vary IPO fund objects and utilise Rs 15.15 Crore of unutilised proceeds. E-voting runs until 17 December 2026.
- Value
- ₹15.15 Cr
- Execution
- E-voting from 18 November 2026 (09:00 a.m.) to 17 December 2026 (05:00 p.m.)
Valor Estate Annual General Meeting
Valor Estate issued a postal ballot notice seeking approval for a related-party consultancy and cost auditor remuneration. E-voting runs until December 17, 2026.
- Execution
- 3 years from 5 November 2026 (Item 1 consultancy term)